W. Joost Lesterhuis
机构: Telethon Kids Institute, University of Western Australia
每年引用次数
引用次数
引用: 10,058
H-指数: 45
I10-指数 : 67
出版物: 149
Immuuntherapie van kanker: belang van dendritische cel.
C.G. Figdor , I.J.M. de Vries , C.J.A. Punt , W.J. Lesterhuis
Tijdschrift Kanker 2 8 -12
2003
Het volgen van therapeutische cellen met magnetische resonantie.
C.G. Figdor , A. Heerschap , P.M. Hoogerbrugge , W.J.G. Oyen
Nederlands Tijdschrift voor Hematologie 4 133 -138
2007
Dendritic cells in cancer immunotherapy.
W.J. Lesterhuis
[S.l. : s.n.]
2010
Vaccine-specific T cell responses in delayed-type hypersensitivity biopsies after dendritic cell vaccination correlate with clinical outcome
C.G. Figdor , M.R. Bernsen , A.C.I. Boullart , N.M. Scharenborg
Annals of Oncology 16 271 -271
2005
Diagnostic image (146). A man with food passage problems. Intrathoracic pancreatic pseudocyst
F. van der Straaten , W.J. Lesterhuis , J. Haringsma
Nederlands Tijdschrift voor Geneeskunde 147 ( 27) 1314 -1314
2003
Skin-Test Infiltrating Lymphocytes Predict Clinical Outcome of Dendritic Cell Based Vaccination in Metastatic Melanoma
K. Bol , E. Aarntzen , W.R. Gerritsen , G. Schreibelt
Annals of Oncology 23
2012
Dendritic cell vaccines in melanoma: From promise to proof?
W.J. Lesterhuis , E.H.J.G. Aarntzen , I.J.M. De Vries , D.H. Schuurhuis
Critical Reviews in Oncology Hematology 66 ( 2) 118 -134
160
2008
Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests
W.J. Lesterhuis , I.J.M. de Vries , D.H. Schuurhuis , A.C.I. Boullart
Annals of Oncology 17 ( 6) 974 -980
76
2006
Dendritic cell-based vaccines in cancer immunotherapy: an update on clinical and immunological results.
W.J. Lesterhuis , I.J.M. de Vries , G.J. Adema , C.J.A. Punt
Annals of Oncology 15
56
2004
Acute generalised exanthematous pustulosis mimicking septic shock.
W.Joost Lesterhuis , Milan Tjioe , Georg A. Stumpenhausen , Reinout van Crevel
The American Journal of Medicine 116 ( 8) 574 -575
10
2004
Molecular Determinants of Autoimmunity and Immune Related Adverse Events in Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors (Auto-Check Study)
Carola Vinuesa , Yoland Antill , Mustafa Khasraw , Anna Nowak
Asia-pacific Journal of Clinical Oncology 15 59 -59
2019
Early Clonal Expansion of Tumour-Infiltrating Lymphocytes Predicts Response to Immune Checkpoint Therapy
Joel Kidman , Rachael Zemek , John-William Sidhom , Debora Correa
2022
Immune stimulatory effects of classical chemotherapy
Joost Lesterhuis , Anna Nowak , Richard Lake
Academic Press
2012
1226 Surgery is a window of opportunity: biomaterial-assisted delivery of immunotherapy reduces local recurrence of soft tissue sarcoma
Ben C Wylie , Francois Rwandamuriye , Cameron Evans , Marck Norrett
Journal for ImmunoTherapy of Cancer 11 ( Suppl 1)
2023
DUAL CHECKPOINT BLOCKADE USING ANTI-PD-1 AND ANTI-CTLA4 COMBINED WITH CISPLATIN CHEMOTHERAPY IS EFFECTIVE IN A MURINE MESOTHELIOMA MODEL
Andrea Khong , Esdy Rozali , Catherine Boylen , Joanne Salmons
JOURNAL OF THORACIC ONCOLOGY 8 S468 -S468
1
2013
Vaccination of colorectal cancer patients with carcinoembryonic antigen peptide-loaded dendritic cells
W. J. Lesterhuis , I. J. de Vries , D. Schuurhuis , N. Scharenborg
Journal of Clinical Oncology 23 ( 16_suppl) 2544 -2544
2005
In situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patients
I. J. M. De Vries , M. R. Bernsen , W. L. van Geloof , N. M. Scharenborg
Cancer Immunology, Immunotherapy 56 ( 10) 1667 -1676
24
2007
Early identification of antigen-specific immune responses in vivo by [18F]-labeled 3'-fluoro-3'-deoxy-thymidine ([18F]FLT) PET imaging.
E. H. J. G. Aarntzen , M. Srinivas , J. H. W. De Wilt , J. F. M. Jacobs
Proceedings of the National Academy of Sciences of the United States of America 108 ( 45) 18396 -18399
50
2011
Comment on "Drug discovery: Turning the titanic"
W. J. Lesterhuis , A. Bosco , R. A. Lake
Science Translational Medicine 6 ( 229)
7
2014
CDKN2A (INK4A-ARF) mutation analysis to distinguish cutaneous melanoma metastasis from a second primary melanoma.
Willeke A. M. Blokx , Joost J. Lesterhuis , Monique P. M. Andriessen , Marian A. J. Verdijk
The American Journal of Surgical Pathology 31 ( 4) 637 -641
11
2007